HA Aniss, C AdLy, AEM Said… - The Egyptian Journal of …, 2012 - ejhm.journals.ekb.eg
Background: despite its vast utility in clinical oncology, the use of doxorubicin is limited by a
potentially fatal cardiomyopathy and congestive heart failure. Free radical formation and …